Skip to main content

Understanding and Treating Ataxia-Telangiectasia (R21)

National Institutes of Health

open
Rolling / OpenLast verified: 2026-06-19

About This Grant

Purpose. The National Institute of Neurological Disorders and Stroke (NINDS), National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHBLI), National Human Genome Research Institute (NHGRI), National Institute on Aging (NIA), National Institute of Child Health and Human Development (NICHD), National Institute on Deafness and Other Communication Disorders (NIDCD), and the National Institute of Environmental Health Sciences (NIEHS), in conjunction with the Ataxia-Telangiectasia Children s Project (A-TCP) and the A-T Ease Foundation, invite research grant applications aimed at understanding or treating Ataxia-Telangiectasia (A-T). The aim of this FOA is to encourage basic, translational and clinical studies to determine how the symptoms of A-T develop, to stimulate the development of resources to further A-T research, to accelerate research into promising therapeutic approaches for A-T and to stimulate progress in A-T research through encouraging and facilitating interdisciplinary interactions. Mechanism of Support. This FOA will utilize the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with two other FOAs of identical scientific scope (R01, PA-07-272 and R03, PA-07-274) that solicit applications under the NIH Traditional Research Project Grant (R01) mechanism, and the NIH Small Research Grant (R03) mechanism, respectively. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. Budget and Project Period. The total project period for an application submitted in response to this funding opportunity may not exceed two years. Direct costs are limited to $275,000 over an R21 two-year period, with no more than $200,000 in direct costs allowed in any single year. The R21 is not renewable. Eligible Organizations: Public/State Controlled Institution of Higher Education; Private Institution of Higher Education; Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education); Nonprofit without 501(c)(3) IRS Status (Other than Institution of Higher Education); Small Business; For-Profit Organization (Other than Small Business); State Government; U.S. Territory or Possession; Indian/Native American Tribal Government (Federally Recognized); Indian/Native American Tribal Government (Other than Federally Recognized); Indian/Native American Tribally Designated Organization; Non-domestic (non-U.S.) Entity (Foreign Organization); Hispanic-serving Institution; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); Alaska Native and Native Hawaiian Serving Institutions; Regional Organization; Other(s): Eligible agencies of the Federal government; Faith-based or community based organizations.

Grant Summary

Understanding and Treating Ataxia-Telangiectasia (R21) is a National Institutes of Health grant providing up to $200K for municipality. Applications are accepted on a rolling basis. Check eligibility and apply with FindGrants.

Focus Areas

education

Eligibility

municipality

How to Apply

Funding Range

Up to $200K

Deadline

Rolling / Open

Complexity
Medium
  1. 1Confirm your organization is eligible for Understanding and Treating Ataxia-Telangiectasia (R21) from National Institutes of Health, checking organization type, location, and any population or project requirements.
  2. 2Gather the required documents and information, including your organization details, project plan, and budget figures.
  3. 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
  4. 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to National Institutes of Health before the deadline.
Start Application

Search & build free — $99 one-time to unlock the export-ready application pack. No subscription.

Don't want to draft it yourself?

We'll draft the complete application against National Institutes of Health's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.

AI Requirement Analysis

Detailed requirements not yet analyzed

Have the NOFO? Paste it below for AI-powered requirement analysis.

0 characters (min 50)

Understanding and Treating Ataxia-Telangiectasia (R21): Frequently Asked Questions

Who is eligible for the Understanding and Treating Ataxia-Telangiectasia (R21)?

Understanding and Treating Ataxia-Telangiectasia (R21) is offered by National Institutes of Health and is generally open to municipality. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.

How much funding does the Understanding and Treating Ataxia-Telangiectasia (R21) provide?

Understanding and Treating Ataxia-Telangiectasia (R21) provides up to $200K per award from National Institutes of Health. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.

When is the Understanding and Treating Ataxia-Telangiectasia (R21) deadline?

Understanding and Treating Ataxia-Telangiectasia (R21) accepts applications on a rolling or ongoing basis, so there is no single fixed deadline. Confirm current timing with the funder, National Institutes of Health, before you apply, and submit as early as possible because rolling programs can close once funds are committed.

How do you apply for the Understanding and Treating Ataxia-Telangiectasia (R21)?

To apply for Understanding and Treating Ataxia-Telangiectasia (R21), confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from National Institutes of Health.

Browse More Grants